E-LIB Suche - Ergebnisse für: Tarin, Malcy

1

Corrigendum to "Preclinical evaluation of drug combinations..:

Decaudin, Didier ; Dit Leitz, Estelle Frisch ; Nemati, Fariba...
European Journal of Cancer. 184 (2023) - p. 199 , 2023

Link: https://doi.org/10.1016/..

2

FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors..:

Tarin, Malcy ; Némati, Fariba ; Decaudin, Didier...
Cancers. 15 (2023) 8 - p. 2280 , 2023

Link: https://doi.org/10.3390/..

3

Glycolysis Dependency as a Hallmark of SF3B1-Mutated Cells:

Vivet-Noguer, Raquel ; Tarin, Malcy ; Canbezdi, Christine...
Cancers. 14 (2022) 9 - p. 2113 , 2022

Link: https://doi.org/10.3390/..

4

L1CAM and laminin vascular network: Association with the hi..:

Barnhill, Raymond ; van Laere, Steven ; Vermeulen, Peter...
Laboratory Investigation. 102 (2022) 11 - p. 1214-1224 , 2022

Link: https://doi.org/10.1038/..

5

Functional and conformational impact of cancer-associated S..:

Canbezdi, Christine ; Tarin, Malcy ; Houy, Alexandre...
Computational and Structural Biotechnology Journal. 19 (2021) - p. 1361-1370 , 2021

Link: https://doi.org/10.1016/..

6

Preclinical evaluation of drug combinations identifies co-i..:

Decaudin, Didier ; Frisch Dit Leitz, Estelle ; Nemati, Fariba...
European Journal of Cancer. 126 (2020) - p. 93-103 , 2020

Link: https://doi.org/10.1016/..

7

Genetic alterations of SUGP1 mimic mutant-SF3B1 splice patt..:

Alsafadi, Samar ; Dayot, Stephane ; Tarin, Malcy...
Oncogene. 40 (2020) 1 - p. 85-96 , 2020

Link: https://doi.org/10.1038/..

8

Emerging Therapeutic Opportunities Based on Current Knowled..:

Vivet-Noguer, Raquel ; Tarin, Malcy ; Roman-Roman, Sergio.
Cancers. 11 (2019) 7 - p. 1019 , 2019

Link: https://doi.org/10.3390/..

9

FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors..:

Tarin, Malcy ; Némati, Fariba ; Decaudin, Didier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136875/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Functional and conformational impact of cancer-associated S..:

Canbezdi, Christine ; Tarin, Malcy ; Houy, Alexandre...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960499/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Genetic alterations of SUGP1 mimic mutant-SF3B1 splice patt..:

Alsafadi, Samar ; Dayot, Stephane ; Tarin, Malcy...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41388-020-01507-5. , 2020

Link: https://hal.sorbonne-uni..

12

Genetic alterations of SUGP1 mimic mutant-SF3B1 splice patt..:

Alsafadi, Samar ; Dayot, Stephane ; Tarin, Malcy...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41388-020-01507-5. , 2020

Link: https://hal.sorbonne-uni..

13

Emerging Therapeutic Opportunities Based on Current Knowled..:

Vivet-Noguer, Raquel ; Tarin, Malcy ; Roman-Roman, Sergio.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678734/. , 2019

Link: http://www.ncbi.nlm.nih...

14

FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors..:

Malcy Tarin ; Fariba Némati ; Didier Decaudin...
Cancer Therapy. , 2023

Link: https://doi.org/10.3390/..

15

FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors..:

Malcy Tarin ; Fariba Némati ; Didier Decaudin...
https://www.mdpi.com/2072-6694/15/8/2280. , 2023

Link: https://doi.org/10.3390/..